3M Company

(New York Stock Exchange)
Somewhat Bullish +50

3M Cut Its Dividend After 64 Years of Raises. Is It Finally a Buy Again?

πŸ“‰ 3M ended its 64-year streak of consecutive dividend raises by cutting its payout following the 2024 spinoff of Solventum.

βš–οΈ The company settled its biggest legal fight regarding AFFF personal injury litigation on November 3, removing a major overhang.

πŸ’° Total annual dividends fell from $3.311 billion in 2023 to $1.175 billion in 2025 due to the spinoff and cash drains.

πŸ“ˆ The current quarterly dividend of $0.78 represents about 34% of the low end of 2026 adjusted EPS guidance.

πŸ”„ Buybacks of $3 billion this year dwarf dividends, while PFAS payments of $1 billion in Q3 drained cash flow.

πŸ“Š CEO William Brown described Q1 2026 as a quarter of strong results with solid sales growth and double-digit EPS growth.

πŸ”­ CFO Anurag Maheshwari expects working capital timing issues to reverse in the fourth quarter, boosting free cash flow.

πŸ’Έ Net pre-tax PFAS payments totaled $3.5 billion in 2025, with Q3 alone seeing a 72.32% drop in operating cash flow.

πŸ“‰ The stock is up 18.46% year-to-date, trading at approximately 20 times forward earnings.

Bullish Signals
  • 3M settled its largest AFFF personal injury litigation on November 3, resolving a major legal uncertainty and potential cash drain.
  • The company raised full-year adjusted EPS guidance to $9.10-$9.15, supported by solid sales growth and continued margin expansion.
  • Q1 2026 results showed double-digit EPS growth and robust free cash flow generation despite working capital timing issues.
  • The board declared a quarterly dividend of $0.78 and approved a new $6 billion share repurchase authorization.
  • Management expects working capital timing issues to reverse in the fourth quarter, potentially improving future cash flow.
Risk Factors
  • Total annual dividends dropped significantly from $3.311 billion in 2023 to $1.175 billion in 2025 following the Solventum spinoff.
  • Net pre-tax PFAS payments reached $3.5 billion in 2025, with a single quarter seeing $1 billion in payments that drove operating cash flow down 72.32%.
  • The company currently pays out about 39% of its free cash flow to dividends, leaving less room for other investments compared to peers.
  • Working capital timing issues negatively impacted Q3 cash flow, though management expects a reversal in the fourth quarter.
Full Analysis
3M Company (NYSE: MMM) has reclassified as an income stock following a significant legal settlement and the resumption of dividend raises after its 2024 spinoff of Solventum. The company recently settled its largest AFFF personal injury litigation, ending a major source of cash drain and uncertainty that had previously impacted its Dividend King status. Financially, 3M reported strong Q1 2026 results with double-digit EPS growth and robust free cash flow generation. Management raised full-year adjusted earnings guidance to $9.10-$9.15 per share, supported by solid sales growth and continued margin expansion. The company currently pays a quarterly dividend of $0.78, representing approximately 34% of its low-end 2026 earnings guidance. Despite the positive outlook, cash outflows remain significant due to ongoing PFAS remediation costs and aggressive share repurchases. In the third quarter alone, net pre-tax PFAS payments reached $1 billion, contributing to a sharp decline in operating cash flow for that period. However, the board has approved a new $6 billion share repurchase authorization alongside the latest dividend declaration. Analysts view 3M as a growth-and-income hybrid with a yield of roughly 1.67% and a forward P/E ratio of about 20x. Key upcoming catalysts include the expected reversal of working capital timing issues in Q4, the schedule for future PFAS settlement payments, and the magnitude of the next dividend increase.